Literature DB >> 8023851

Mutations participating in interallelic complementation in propionic acidemia.

R A Gravel1, B R Akerman, A M Lamhonwah, M Loyer, A Léon-del-Rio, I Italiano.   

Abstract

Deficiency of propionyl-CoA carboxylase (PCC; alpha 4 beta 4) results in the rare, autosomal recessive disease propionic acidemia. Cell fusion experiments have revealed two complementation groups, pccA and pccB, corresponding to defects of the PCCA (alpha-subunit) and PCCB (beta-subunit) genes, respectively. The pccBCC group includes subgroups, pccB and pccC, which are thought to reflect interallelic complementation between certain mutations of the PCCB gene. In this study, we have identified the mutations in two pccB, one pccC, and two pccBC cell lines and have deduced those alleles participating in interallelic complementation. One pccB line was a compound heterozygote of Pro228Leu and Asn536Asp. The latter mutation was also detected in a noncomplementing pccBC line. This leaves Pro228Leu responsible for complementation in the pccB cells. The second pccB line contained an insertional duplication, dupKICK140-143, and a splice mutation IVS + 1 G-->T, located after Lys466. We suggest that the dupKICK mutation is the complementing allele, since the second allele is incompatible with normal splicing. The pccC line studied was homozygous for Arg410Trp, which is necessarily the complementing allele in that line. For a second pccC line, we previously had proposed that delta Ile408 was the complementing allele. We now show that its second allele, "Ins.Del," a 14-bp deletion replaced by a 12-bp insertion beginning at codon 407, fails to complement in homozygous form. We conclude that the interallelic complementation results from mutations in domains that can interact between beta-subunits in the PCC heteromer to restore enzymatic function. On the basis of sequence homology with the Propionibacterium shermanii transcarboxylase 12S subunit, we suggest that the pccC domain, defined by Ile408 and Arg410, may involve the propionyl-CoA binding site.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8023851      PMCID: PMC1918217     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  36 in total

1.  Assignment of the alpha and beta chains of human propionyl-CoA carboxylase to genetic complementation groups.

Authors:  A M Lam Hon Wah; K F Lam; F Tsui; B Robinson; M E Saunders; R A Gravel
Journal:  Am J Hum Genet       Date:  1983-09       Impact factor: 11.025

2.  Genetic characterization of the folding domains of the catalytic chains in aspartate transcarbamoylase.

Authors:  D D Jenness; H K Schachman
Journal:  J Biol Chem       Date:  1983-03-10       Impact factor: 5.157

3.  Location of amino acid alterations in mutants of aspartate transcarbamoylase: Structural aspects of interallelic complementation.

Authors:  H K Schachman; C D Pauza; M Navre; M J Karels; L Wu; Y R Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

4.  Purification of human liver propionyl-CoA carboxylase by carbon tetrachloride extraction and monomeric avidin affinity chromatography.

Authors:  R A Gravel; K F Lam; D Mahuran; A Kronis
Journal:  Arch Biochem Biophys       Date:  1980-05       Impact factor: 4.013

5.  Interallelic complementation in an inborn error of metabolism: genetic heterogeneity in argininosuccinate lyase deficiency.

Authors:  R R McInnes; V Shih; S Chilton
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

6.  The defective proton-ATPase of uncD mutants of Escherichia coli. Identification by DNA sequencing of residues in the beta-subunit which are essential for catalysis or normal assembly.

Authors:  D Parsonage; T M Duncan; S Wilke-Mounts; F A Kironde; L Hatch; A E Senior
Journal:  J Biol Chem       Date:  1987-05-05       Impact factor: 5.157

7.  Kinetic analysis of genetic complementation in heterokaryons of propionyl CoA carboxylase-deficient human fibroblasts.

Authors:  B Wolf; H F Willard; L E Rosenberg
Journal:  Am J Hum Genet       Date:  1980-01       Impact factor: 11.025

8.  Complementation analysis of locus for hypoxanthine guanine phosphoribosyltransferase in Chinese hamster cells.

Authors:  N I Shapiro; E V Luss; L V Volkova; H V Moiseenko
Journal:  Somat Cell Mol Genet       Date:  1985-03

9.  Cloning and screening with nanogram amounts of immunopurified mRNAs: cDNA cloning and chromosomal mapping of cystathionine beta-synthase and the beta subunit of propionyl-CoA carboxylase.

Authors:  J P Kraus; C L Williamson; F A Firgaira; T L Yang-Feng; M Münke; U Francke; L E Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  9 in total

1.  Human argininosuccinate lyase: a structural basis for intragenic complementation.

Authors:  M A Turner; A Simpson; R R McInnes; P L Howell
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

2.  N-carbamylglutamate augments ureagenesis and reduces ammonia and glutamine in propionic acidemia.

Authors:  Nicholas Ah Mew; Robert McCarter; Yevgeny Daikhin; Itzhak Nissim; Marc Yudkoff; Mendel Tuchman
Journal:  Pediatrics       Date:  2010-06-21       Impact factor: 7.124

3.  Unusual presentation of propionic acidaemia as isolated cardiomyopathy.

Authors:  T M Lee; L J Addonizio; B A Barshop; W K Chung
Journal:  J Inherit Metab Dis       Date:  2009-02-24       Impact factor: 4.982

4.  Intragenic complementation of amino and carboxy terminal SMN missense mutations can rescue Smn null mice.

Authors:  Vicki L McGovern; Kaitlyn M Kray; W David Arnold; Sandra I Duque; Chitra C Iyer; Aurélie Massoni-Laporte; Eileen Workman; Aalapi Patel; Daniel J Battle; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2020-11-01       Impact factor: 6.150

5.  Human propionyl-CoA carboxylase beta subunit gene: exon-intron definition and mutation spectrum in Spanish and Latin American propionic acidemia patients.

Authors:  P Rodríguez-Pombo; J Hoenicka; S Muro; B Pérez; C Pérez-Cerdá; E Richard; L R Desviat; M Ugarte
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

Review 6.  Methylmalonic and propionic acidemias: clinical management update.

Authors:  Jamie L Fraser; Charles P Venditti
Journal:  Curr Opin Pediatr       Date:  2016-12       Impact factor: 2.856

7.  Rescue of progeria in trichothiodystrophy by homozygous lethal Xpd alleles.

Authors:  Jaan-Olle Andressoo; Judith Jans; Jan de Wit; Frederic Coin; Deborah Hoogstraten; Marieke van de Ven; Wendy Toussaint; Jan Huijmans; H Bing Thio; Wibeke J van Leeuwen; Jan de Boer; Jean-Marc Egly; Jan H J Hoeijmakers; Gijsbertus T J van der Horst; James R Mitchell
Journal:  PLoS Biol       Date:  2006-10       Impact factor: 8.029

Review 8.  Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia.

Authors:  Matthias R Baumgartner; Friederike Hörster; Carlo Dionisi-Vici; Goknur Haliloglu; Daniela Karall; Kimberly A Chapman; Martina Huemer; Michel Hochuli; Murielle Assoun; Diana Ballhausen; Alberto Burlina; Brian Fowler; Sarah C Grünert; Stephanie Grünewald; Tomas Honzik; Begoña Merinero; Celia Pérez-Cerdá; Sabine Scholl-Bürgi; Flemming Skovby; Frits Wijburg; Anita MacDonald; Diego Martinelli; Jörn Oliver Sass; Vassili Valayannopoulos; Anupam Chakrapani
Journal:  Orphanet J Rare Dis       Date:  2014-09-02       Impact factor: 4.123

9.  Severity modeling of propionic acidemia using clinical and laboratory biomarkers.

Authors:  Oleg A Shchelochkov; Irini Manoli; Paul Juneau; Jennifer L Sloan; Susan Ferry; Jennifer Myles; Megan Schoenfeld; Alexandra Pass; Samantha McCoy; Carol Van Ryzin; Olivia Wenger; Mark Levin; Wadih Zein; Laryssa Huryn; Joseph Snow; Colby Chlebowski; Audrey Thurm; Jeffrey B Kopp; Kong Y Chen; Charles P Venditti
Journal:  Genet Med       Date:  2021-05-18       Impact factor: 8.822

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.